SD-Ahrem2Sage |
serum total bilirubin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood bilirubin amount |
female |
84 days
| 4 |
0.05 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0 |
106377 |
3025 |
SD-Ahrem2Sage |
serum total protein level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood total protein amount |
male |
84 days
| 5 |
66.0 |
g/dl |
3.0 |
6.71 |
automated serum analysis |
|
0 |
106383 |
3025 |
SD-Ahrem2Sage |
serum triglyceride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood triglyceride amount |
male |
84 days
| 5 |
128.4 |
mg/dl |
26.0 |
58.14 |
automated serum analysis |
|
0 |
106403 |
3025 |
SD-Ahrem2Sage |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
male |
84 days
| 5 |
101.0 |
mmol/l |
2.0 |
4.47 |
automated serum analysis |
|
0 |
106427 |
3025 |
SD-Ahrem2Sage |
serum calcium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood calcium amount |
male |
84 days
| 5 |
13.1 |
mg/dl |
0.7 |
1.57 |
automated serum analysis |
|
0 |
106431 |
3025 |
SD-Ahrem2Sage |
serum calcium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood calcium amount |
female |
84 days
| 4 |
13.9 |
mg/dl |
0.4 |
0.8 |
automated serum analysis |
|
0 |
106433 |
3025 |
SD-Ahrem2Sage |
serum total bilirubin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood bilirubin amount |
male |
84 days
| 5 |
0.06 |
mg/dl |
0.02 |
0.04 |
automated serum analysis |
|
0 |
106375 |
3025 |
SD-Ahrem2Sage |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
female |
84 days
| 4 |
0.38 |
mg/dl |
0.05 |
0.1 |
automated serum analysis |
|
0 |
106413 |
3025 |
SD-Ahrem2Sage |
serum total protein level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood total protein amount |
female |
84 days
| 4 |
65.0 |
g/dl |
4.0 |
8.0 |
automated serum analysis |
|
0 |
106385 |
3025 |
SD-Ahrem2Sage |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84 days
| 5 |
1.8 |
null |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106395 |
3025 |
SD-Ahrem2Sage |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
female |
84 days
| 4 |
2.0 |
null |
0.1 |
0.2 |
automated serum analysis |
|
0 |
106397 |
3025 |
SD-Ahrem2Sage |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
male |
84 days
| 5 |
102.6 |
mg/dl |
12.8 |
28.62 |
automated serum analysis |
|
0 |
106399 |
3025 |
SD-Ahrem2Sage |
serum glucose level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood glucose amount |
male |
84 days
| 5 |
288.6 |
mg/dl |
59.3 |
132.6 |
automated serum analysis |
|
0 |
106415 |
3025 |
SD-Ahrem2Sage |
serum glucose level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood glucose amount |
female |
84 days
| 4 |
333.3 |
mg/dl |
90.0 |
180.0 |
automated serum analysis |
|
0 |
106417 |
3025 |
SD-Ahrem2Sage |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84 days
| 4 |
99.0 |
mmol/l |
2.3 |
4.6 |
automated serum analysis |
|
0 |
106429 |
3025 |
SD-Ahrem2Sage |
serum potassium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood potassium amount |
female |
84 days
| 4 |
8.2 |
mmol/l |
0.6 |
1.2 |
automated serum analysis |
|
0 |
106425 |
3025 |
SD-Ahrem2Sage |
serum phosphate level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood phosphate amount |
female |
84 days
| 4 |
14.8 |
mg/dl |
2.5 |
5.0 |
automated serum analysis |
|
0 |
106437 |
3025 |
SD-Ahrem2Sage |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
female |
84 days
| 4 |
77.3 |
U/l |
21.6 |
43.2 |
automated serum analysis |
|
0 |
106365 |
3025 |
SD-Ahrem2Sage |
serum albumin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84 days
| 5 |
4.2 |
g/dl |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106387 |
3025 |
SD-Ahrem2Sage |
serum globulin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood globulin amount |
male |
84 days
| 5 |
2.4 |
g/dl |
0.2 |
0.45 |
automated serum analysis |
|
0 |
106391 |
3025 |
SD-Ahrem2Sage |
serum urea nitrogen level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood urea nitrogen amount |
male |
84 days
| 5 |
22.6 |
mg/dl |
2.3 |
5.14 |
automated serum analysis |
|
0 |
106407 |
3025 |
SD-Ahrem2Sage |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
male |
84 days
| 5 |
0.3 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0 |
106411 |
3025 |
SD-Ahrem2Sage |
serum albumin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
female |
84 days
| 4 |
4.3 |
g/dl |
0.3 |
0.6 |
automated serum analysis |
|
0 |
106389 |
3025 |
SD-Ahrem2Sage |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
female |
84 days
| 4 |
140.8 |
U/l |
54.5 |
109.0 |
automated serum analysis |
|
0 |
106373 |
3025 |
SD-Ahrem2Sage |
serum sodium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood sodium amount |
male |
84 days
| 5 |
149.2 |
mmol/l |
1.1 |
2.46 |
automated serum analysis |
|
0 |
106419 |
3025 |
SD-Ahrem2Sage |
serum potassium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood potassium amount |
male |
84 days
| 5 |
7.6 |
mmol/l |
0.7 |
1.57 |
automated serum analysis |
|
0 |
106423 |
3025 |
SD-Ahrem2Sage |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
female |
84 days
| 4 |
126.5 |
U/l |
14.7 |
29.4 |
automated serum analysis |
|
0 |
106369 |
3025 |
SD-Ahrem2Sage |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
female |
84 days
| 4 |
106.5 |
mg/dl |
17.5 |
35.0 |
automated serum analysis |
|
0 |
106401 |
3025 |
SD-Ahrem2Sage |
serum urea nitrogen level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood urea nitrogen amount |
female |
84 days
| 4 |
23.0 |
mg/dl |
1.6 |
3.2 |
automated serum analysis |
|
0 |
106409 |
3025 |
SD-Ahrem2Sage |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
male |
84 days
| 5 |
59.4 |
U/l |
14.6 |
32.65 |
automated serum analysis |
|
0 |
106363 |
3025 |
SD-Ahrem2Sage |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
male |
84 days
| 5 |
154.4 |
U/l |
8.4 |
18.78 |
automated serum analysis |
|
0 |
106367 |
3025 |
SD-Ahrem2Sage |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
male |
84 days
| 5 |
77.8 |
U/l |
14.8 |
33.09 |
automated serum analysis |
|
0 |
106371 |
3025 |
SD-Ahrem2Sage |
serum triglyceride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood triglyceride amount |
female |
84 days
| 4 |
105.7 |
mg/dl |
28.1 |
56.2 |
automated serum analysis |
|
0 |
106405 |
3025 |
SD-Ahrem2Sage |
serum phosphate level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood phosphate amount |
male |
84 days
| 5 |
12.7 |
mg/dl |
1.9 |
4.25 |
automated serum analysis |
|
0 |
106435 |
3025 |
SD-Ahrem2Sage |
serum globulin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood globulin amount |
female |
84 days
| 4 |
2.2 |
g/dl |
0.1 |
0.2 |
automated serum analysis |
|
0 |
106393 |
3025 |
SD-Ahrem2Sage |
serum sodium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood sodium amount |
female |
84 days
| 4 |
146.8 |
mmol/l |
2.1 |
4.2 |
automated serum analysis |
|
0 |
106421 |
3025 |